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Abstract
Background: Structural Magnetic Resonance Imaging (sMRI) of the brain is employed in the
assessment of a wide range of neuropsychiatric disorders. In order to improve statistical power in
such studies it is desirable to pool scanning resources from multiple centres. The CaliBrain project
was designed to provide for an assessment of scanner differences at three centres in Scotland, and
to assess the practicality of pooling scans from multiple-centres.
Methods: We scanned healthy subjects twice on each of the 3 scanners in the CaliBrain project
with T1-weighted sequences. The tissue classifier supplied within the Statistical Parametric Mapping
(SPM5) application was used to map the grey and white tissue for each scan. We were thus able to
assess within scanner variability and between scanner differences. We have sought to correct for
between scanner differences by adjusting the probability mappings of tissue occupancy (tissue
priors) used in SPM5 for tissue classification. The adjustment procedure resulted in separate sets
of tissue priors being developed for each scanner and we refer to these as scanner specific priors.
Results: Voxel Based Morphometry (VBM) analyses and metric tests indicated that the use of
scanner specific priors reduced tissue classification differences between scanners. However, the
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metric results also demonstrated that the between scanner differences were not reduced to the
level of within scanner variability, the ideal for scanner harmonisation.
Conclusion: Our results indicate the development of scanner specific priors for SPM can assist in
pooling of scan resources from different research centres. This can facilitate improvements in the
statistical power of quantitative brain imaging studies.
Background
Structural Magnetic Resonance Imaging (sMRI) of the
brain is employed in the assessment of a wide range of
neuropsychiatric disorders. Voxel Based Morphometry
(VBM) has been established as a leading method for ana-
lysing large sMRI studies. VBM is a fully automated proc-
ess that is used to localise differences in brain parenchyma
[1,2]. The VBM implementation segments T1-weighted
MRI scans into voxel-wise mappings of grey and white tis-
sue and Cerebrospinal Fluid (CSF). It provides for statisti-
cal comparisons of these mappings within clinical studies.
VBM requires good quality co-registration at the voxel
level and it is sensitive to differences between MRI scan-
ners. Reports of VBM analyses that pool scans from differ-
ent sites for analysis have employed validity assessments
[3,4]. In a validity assessment, a VBM contrast of control
subjects between the contributing sites is used to map the
regions of significant difference between scanners. A
masking image that charts these regions is formed. These
masked regions are excluded from VBM reporting as
results in these regions could be driven by artifactual scan-
ner differences [5,6].
In VBM the use of validity masking is undesirable because
it limits the analyses to less than whole brain coverage. As
VBM draws its inferences from voxel-wise comparisons it
is necessary to apply fine grain corrections of the sMRI tis-
sue classification in order to avoid validity masking. We
investigated making such corrections by scanning the
same fourteen healthy subjects, twice, at three scanning
sites in Scotland with T1-weighted sequences. These acqui-
sitions were implemented as part of the CaliBrain study,
and we have complete sets of scans for thirteen subjects.
The three scanners in the CaliBrain project were matched
on the basis of vendor, field strength and head coil type.
In this investigation we used an established sMRI analysis
tool Statistical Parametric Mapping (SPM5) [1] to seg-
ment the T1 scans into grey and white tissue maps and
CSF maps.
Baseline analyses of the Calibrain T1  segmentations
revealed significant differences between the scanners and
these differences were of an order that would require
validity masking. We investigated the practicality of com-
pensating for scanner differences through the adjustments
in the SPM5 segmentation procedure. The SPM segmenta-
tion protocol employs spatial priors that map the proba-
ble distributions of grey and white tissue and CSF. These
priors account for the low frequency variability in tissue
presentation across the brain. We adjusted these prior
mappings to compensate for the scanner differences. In
this process we developed separate sets of priors for each
scanner. As above, we refer to these as scanner specific pri-
ors. In VBM analyses of the segmentations based upon
scanner specific priors, we found that the baseline differ-
ences which had indicated a requirement for validity
masking were removed.
In addition to VBM analyses we applied metric tests to
quantify within scanner variability and between scanner
differences. These metrics were applied at baseline and on
the adjusted segmentations. The metric results demon-
strated that the use scanner specific priors can reduce the
tissue classification differences between scanners. How-
ever, these reductions were not sufficient to bring the
between scanner differences down to the level of within
scanner variability.
Methods
Study Design
The CaliBrain project was designed to allow for the assess-
ment of differences between scanners and for these differ-
ences to be considered in the context of within scanner
variability. For this, healthy subjects travelled twice to
each of the three scanning centres within a six months
period. At each visit the subjects received a T1-weighted
structural MRI scan. We used SPM5 [1] to segment the
structural scans into baseline grey and white tissue maps
and CSF maps. The SPM priors used in these baseline tis-
sue classifications were taken from a study of psychosis
which employed a scan sequence that was equivalent to
that used for the CaliBrain acquisitions [7]. The priors in
the psychosis study were drawn from scans of young
adults with a family history of schizophrenia and control
subjects with no family history of psychosis. All 93 sub-
jects in this study were well at time of scanning.
The practice of adjusting the SPM tissue priors specifically
for a cohort acquired at one scanning centre is well estab-
lished [8-12] and the importance of matching the spatial
priors to the investigated population was demonstrated in
a study of healthy young adults [13]. We have extended
the practice of adjusting the SPM priors adjustment so that
they provide compensation for scanner differences. ToBMC Medical Imaging 2009, 9:8 http://www.biomedcentral.com/1471-2342/9/8
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achieve scanner level compensation we implemented an
iterative adjustment protocol that employed proportional
feedback to develop scanner specific priors for each scan-
ner. We illustrate the operation of this protocol by ran-
domly selecting six subjects from the CaliBrain project.
We used the 1st round scans of these subjects to develop
the scanner specific priors. These priors were then used to
segment all the CaliBrain T1 scans and this gave the seg-
mentations for our adjusted analyses. VBM contrast anal-
yses and metrics were used to assess the scanner
differences at baseline and for adjusted segmentations.
The seven subjects that were excluded from the scanner
specific process formed a test group upon which we could
assess the viability of our protocol.
Data Acquisition
The CaliBrain project acquired MRI brain scans from three
imaging research centres: The Department of Radiology,
University of Aberdeen; The Division of Psychiatry and
The SFC Brain Imaging Research Centre within The Centre
for Clinical Brain Sciences (CCBS) at The University of
Edinburgh; and The Department of Clinical Physics, NHS
Greater Glasgow South University Hospitals Division. The
three scanners used were manufactured by General Elec-
tric (GE Healthcare, Milwaukee, Wisconsin) and had pri-
mary field strengths of 1.5T. The scanners are nominated
within this report as scanners 'A, B and C'.
Fourteen healthy participants (10 male, mean age 36.3,
age range 22–51 years) took part in the study. All partici-
pants were native English speakers, right-handed (self
reported), met the standard MRI safety criteria and had no
history of diagnosed neurological disorder, major psychi-
atric disorder or treatment with psychotropic medication,
including treatment for substance misuse. The partici-
pants were not paid, but they were reimbursed for
expenses. All participants provided written informed con-
sent and the study was approved by the local research eth-
ics committees. The scan records were incomplete for one
subject and thus the harmonisation methods in the Cali-
Brain project were conducted on the basis of 13 healthy
participants.
Three General Electric 1.5T scanners were used in this
study, with some inevitable differences in hardware and
software versions. In site A scanning was conducted with
a General Electrics (GE) 1.5T Signa NVi/CVi scanner (soft-
ware version 9.1; gradients with max. amplitude 40 mT/m
and max. slew rate 150 T/m/s; standard quadrature head
coil). In site B scanning was conducted with a General
Electrics (GE) 1.5T Signa LX scanner (software version
9.1M4; Echo-speed gradients with max. amplitude 22 mT/
m and max. slew rate 120 T/m/s; standard quadrature
head coil). In site C scanning was conducted with a Gen-
eral Electrics (GE) 1.5T Signa scanner (software version
11M3/11M4SP1; gradients with max. amplitude 40 mT/
m and max. slew rate 150 T/m/s; standard quadrature
head coil).
All subjects participated in six scanning sessions, two at
each of the three sites. The time lapse between scans at
each site was nominally two weeks. The scanning param-
eters were kept constant across the three scanners, allow-
ing for minor deviations arising from differences in
scanner hardware and software. A high resolution T1-
weighted scan was acquired using a 3D inversion recov-
ery-prepared fast gradient echo volume sequence with the
following parameters: orientation coronal; repetition
time (TR) of 5.9 ms (sites A and C) or 8.2 ms (site B); echo
time (TE) of 1.9 ms (site A) or 3.3 ms (site B) or 1.4 ms
(site C); slice thickness = 1.7 mm without a gap; inversion
time (TI) 600 ms; matrix = 256 × 256, voxel within slice
dimension = 0.86 mm square; field of view (FOV) = 220
mm2; flip angle = 15°; 128 slices.
VBM Preprocessing and Segmentation
Prior to SPM5 segmentation, co-registration and reslicing
procedures were applied to ensure that all the scans were
aligned to the anterior-posterior commissure axis (AC-
PC) in the standard MNI template space. As part of this
process the scans were re-sampled to a resolution of 1 × 1
× 1 mm. The SPM5 segmentation at baseline was imple-
mented using a study specific priors set that had been pre-
viously developed for a study of psychosis [7]. The SPM5
adjusted segmentations were obtained using the scanner
specific priors derived in our priors adjustment procedure.
The SPM5 segmentations were run using the default set-
tings, the 'Number of Gaussians per class' was set to [2 2
2] and the 'Bias regularization' was set to 'medium'. In
keeping with the established practice in psychosis research
the segmented results were output as unmodulated and
normalized to the MNI template. The normalization
employed the SPM5 default normalization with the 'Non-
linear Frequency Cutoff = 25'. Also, in keeping with estab-
lished VBM practice for psychosis in tissue density
analyses the SPM5 segmentations were smoothed using
an isotropic 12 mm Full Width Half Maximum (FWHM)
kernel.
Procedure for creating Scanner Specific Priors
Our iterative procedure that compensates for scanner dif-
ferences employs proportional feedback to develop sets of
scanner specific priors for use in the adjusted SPM5 seg-
mentations. The process flow diagram in Figure 1 gives an
overview of this procedure. We designate one scanner as
the target scanner and a second as the object scanner. The
scans from the target scanner are segmented using SPM5
and for this segmentation the priors were taken from our
psychosis study [7]. The priors applied to the target scan-
ner remain unchanged throughout the run of the iterativeBMC Medical Imaging 2009, 9:8 http://www.biomedcentral.com/1471-2342/9/8
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procedure. The object scanner segmentation is also initial-
ised with the priors taken from our psychosis study [7].
Then through our iterative procedure these object scanner
priors are incrementally adjusted. These adjustments are
set to compensate for the segmentation differences
between the target and object scanners.
The process illustrated in Figure 1 adjusts the object priors
through comparisons based upon grey and white segmen-
tations. This dual dependence of the adjusted priors on
grey and white tissue is accommodated by allowing the
iteration process to alternate the prime comparison
between the grey and white tissue types. Thus for every
other iteration the prime tissue comparison is applied to
the grey segment and this is interspersed with the prime
tissue comparison being made on the white segment.
When grey is the prime comparison segment we adjust the
grey prior to correct for the voxel level differences found
between the target and object scanners and also at the
voxel level we apply a balancing adjustment to the white
or CSF prior to ensure that the sum of the priors at the
voxel level is maintained at its nominal sum of unity. Sim-
ilarly when the prime comparison is made upon the white
segment we adjust the white prior to correct for the differ-
ences between the target and object scanner and we apply
a balancing adjustment to the grey or CSF prior. In VBM
assessments of psychosis CSF presentation is not an estab-
lished measure of interest, thus we do not assign CSF the
prime status within the priors adjustment process.
On a subject by subject basis the prime comparison seg-
mentations obtained from the target and object scanners
are subtracted. These subtractions were implemented at
the voxel-level and the differences were averaged across
the subjects included in the priors adjustment process.
The averaged voxel-level differences were used to form a
difference image that was then smoothed to suppress sam-
pling noise and reduce subject bias. Next a proportion of
the smoothed difference image is used to adjust the grey,
white and CSF priors applied to the object scanner. These
adjusted priors are then made available for the next itera-
Process Flow diagram Figure 1
Process Flow diagram. Process Flow for procedure that develops scanner specific priors to correct for segmentation differ-
ences between the object and target scanners. Adjustment of the object scanner priors is used to minimise the difference 
between the scanners. The final adjusted object scanner priors are output as the scanner specific priors.BMC Medical Imaging 2009, 9:8 http://www.biomedcentral.com/1471-2342/9/8
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tion of the procedure. This process is repeated until the
segmentations given by the object scanner converge with
those given by the target scanner. We assess this conver-
gence through the use of metrics described below.
The evaluation of the prime difference image Pgdiff for the
grey segment G is given in equation (1). When the prime
comparison segment is white W, the difference image
Pwdiff is given by equation (2). In these calculations of the
prime difference images, the processed scans are desig-
nated by subscripts (subject, visit, scanner), with N = 6, the
number of compared subjects. These comparisons were
limited to the 1st round scans. The averaging across the
adjustment subjects suppresses individual differences.
When the primary segment is grey the adjusted prior adjG-
prior is given by equation (3). In this voxel-level process
the current grey prior curGprior has a proportion beta of
the smoothed prime difference sPgdiff image subtracted.
When the prime comparison segment is grey the evalua-
tions of the adjusted white adjWprior  and CSF priors
adjCprior are given by equations (4) and (5). In these the
changes applied to the grey prior are balanced by equiva-
lent additions to the white or CSF priors. At the voxel level
we test the relative occupancy of the white and CSF priors
and assign the balancing adjustment to which ever prior
exhibits greater occupancy. When the prime comparison
segment is white the adjusted priors evaluations are equiv-
alent to those given in equations (3), (4) and (5) with the
exceptions that the prime difference image is given by
Pwdiff and the grey and white priors are interchanged. This
averaged difference images Pgdiff and Pwdiff are smoothed
using an isotropic kernel, with a FWHM of 10 mm.
Smoothing at this level suppresses sampling noise and
limits the subject bias that results from the relatively small
number of subjects that we have used to create the scanner
specific priors
The value of beta determines the proportion of the differ-
ence image that is used to adjust the priors for the follow-
ing iteration of the protocol. The setting of beta has an
important bearing on this protocol. A high setting for beta
could lead to instability whilst using value that is too low
could result in sluggish convergence. As part of the devel-
opment of this method, we experimented with the beta
setting and found that setting beta to 0.33 or greater could
lead to instability in the priors adjustment process. We
found that a beta setting of 0.15 allowed for stable conver-
gence of the segmentations from different scanners. We
found that further reductions of the beta value did not
improve the degree of convergence that was obtained
from the adjustment process. The reductions in beta did
increase the number iterations required to attain conver-
gence. We ran a between scanner distance metric to assess
the degree of convergence between the target and object
scanners. We terminated the adjustment procedure when
the incremental change in the between scanner distance
was less than 0.1% and held at this level in subsequent
iterations.
Testing Scanner Specific Priors Procedure
We tested our priors adjustment procedure by randomly
selecting six subjects from the CaliBrain project. We
applied the scanner specific priors adjustment to the 1st
round scans of these subjects. We designated the scanners
in the CaliBrain project as scanners A, B and C. Scanner A
was set as the target scanner and scanner B as the object
scanner and we developed a set of scanner specific priors
for scanner B. We also developed scanner specific priors
for scanner C with scanner A set as the target scanner.
Throughout these adjustment procedures the priors set
used for scanner A was fixed as the priors drawn from our
study of psychosis [7]. The scanner specific priors devel-
oped for scanners B and C were initialised with the priors
from our psychosis study. The choice of scanner A for as
the target scanner was based upon the baseline metric
results that indicated that scanner A has a low within scan-
ner variability and that it exhibited the lowest overall
between scanner differences.
VBM Statistical Analysis
Using the SPM5 application we implemented VBM statis-
tical analyses of the grey and white segmentations at base-
line and for our adjusted segmentations. In these we
treated the visits and scanners as separate grouping com-
ponents and thus formed a factorial analysis matrix that
was composed of six groups. We designated the Independ-
ence variable as 'NO' to account for the fact that we have
repeated measures on the same subjects. We reported the
overall F-test for main effect of scanner in the CaliBrain
Pgdiff
N
GG n, Obje ct n, T et
n=
N
=
1
visit, . visit, arg
1
() () ( ) − ∑ (1)
Pwdiff
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study. Also, we used this design matrix to report t-test con-
trast results for within scanner variability and between
scanner differences. The t-tests for between scanner differ-
ences were made by combining the two visits at each scan-
ner. All t-tests and the F-test were carried out with an
uncorrected threshold of 0.001, and we reported Family
wise error (FWE) correction for multiple comparisons. All
groups were composed of the same subjects and as the
scans were all acquired within a six month period there
was no requirement to covary for age or gender.
Voxel-wise distance metrics
We employed a percentage distance metric to quantify the
within scanner variability and between scanner differ-
ences. In SPM, tissue occupancy is assigned at the voxel
level for grey, white and CSF as full occupancy or as partial
volumes. At full occupancy the voxel is assigned as either
grey or white or CSF with occupancy of 1.0. At the inter-
face between tissue types partial occupancy is assigned on
a continuous scale from 0.0 to 1.0 and the sum of the
assigned occupancy for each voxel does not exceed 1.0.
In order to evaluate the distance between two tissue clas-
sifications we computed as a percentage the absolute dis-
tance. The general form of the absolute percentage
distance computation is illustrated in equation (6) where
we compare two voxels V1 and V2. This reports the per-
centage absolute difference with respect to the average
value of the compared voxels. We chose this metric
because it accentuates the differences in the compared seg-
mentations.
In keeping with established VBM analyses the metrics
were applied to the smoothed segmentations and limited
to valid-voxels where the compared segments had occu-
pancy of greater than 0.05. The summary value reported
by the metric is an average of the absolute percentage dif-
ference found at the valid voxels in the normalised and
smoothed segmentations. The metrics are applied on a
subject basis and for each subject we evaluate the within
scanner variability for scanners A, B and C and we evaluate
the between scanner differences for the scanner pairs AB,
AC and BC. A paired sample t-test is used to compare the
baseline and adjusted metric results and to report the
mean difference and its significance.
Results
Metric Results
We applied the percentage distance metric to the grey mat-
ter segmentations to obtain measures of within scanner
variability and between scanner differences. The metric
was applied at baseline and after adjustment using the
scanner specific priors. Table 1 gives the grey matter metric
results averaged across the six subjects used to generate the
scanner specific priors. Table 2 gives the grey matter metric
results averaged across the seven subjects who were
excluded from the process that developed the scanner spe-
cific priors. In Tables 1 and 2 we note the mean difference
between baseline and adjusted analyses and we give the
p_value for the paired sample t-test as measure of signifi-
cance in the adjustment process.
VBM Analyses
We ran VBM baseline and adjusted analyses on the nor-
malised and smoothed segmentations obtained for the
seven subjects who were excluded from the prior's adjust-
ment procedure. In these analyses we treat the visits and
scanners as separate grouping components and thus form
a design matrix composed of six groups. We applied an F-
test to consider the main effect of scanner and t-tests to
investigate within and between scanner differences. All
groups are composed of the same seven subjects and as
the scans were all conducted within a six month period
there is no requirement to co-vary for age or gender.
Baseline VBM Results
The F-test main effect Maximum Intensity Projection
(MIP) for the baseline grey matter analysis is illustrated in
Figure 2. The F-test was carried out with an uncorrected
AbsolutePercentageDis ce
V1 V2
V1 V2
tan
200
=
∗−
+
||
()
(6)
Table 1: Grey matter metric results for the subjects used in priors generation
Scanner Comparison Baseline* Adjusted* Mean Difference (paired sample significance)
AA 2.1 (0.5) 2.1 (0.5) 0.00 (p < 1.00)
BB 3.0 (0.5) 3.0 (0.4) 0.02 (p < 0.79)
CC 2.1 (0.6) 2.1 (0.5) 0.02 (p < 0.36)
AB 7.2 (0.8) 3.7 (0.4) 3.5 (p < 0.001)
BC 8.0 (0.8) 4.0 (0.6) 4.0 (p < 0.001)
AC 3.1 (0.4) 2.3 (0.3) 0.8 (p < 0.001)
Grey matter metric results averaged over the six subjects used to generate the scanner specific priors. For the within and between scanner 
comparison both baseline and adjusted absolute percentage distances are recorded.
*Absolute Percentage distance % (std dev)BMC Medical Imaging 2009, 9:8 http://www.biomedcentral.com/1471-2342/9/8
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threshold of (p < 0.001). This reveals significant scanner
effects in the frontal lobes, temporal poles, the thalamus,
brain-stem, parietal lobes and occipital lobes. The results
of the baseline grey matter F-test are given in Table 3. In
this we report the significant maximal voxels giving the
MNI coordinate and the anatomical location. We report
the Family Wise Error (FWE) corrected p-value of maximal
voxel and we also report the extent of the cluster associ-
ated with the maximal voxel.
We investigated the source of these baseline grey matter
differences by applying t-test contrasts. t-test comparisons
of 1st and 2nd round scans of each scanner revealed that
there were no significant within scanner differences. t-test
comparisons between the scanners revealed that there
were no significant differences between scanners A and C.
t-test comparisons between scanners B and C were found
to replicate the differences reported in the F-test for main
effect of scanner. t-test comparisons between scanners B
and A also demonstrated replication of the differences
reported in the F-test for main effect of scanner.
The F-test results for the baseline white matter VBM anal-
ysis are given in Figure 3 and Table 4. This illustrates the
spatial distribution of the between scanner differences
with significant differences in the right middle frontal
gyrus and the thalamus. We investigated sources of these
baseline white matter differences by applying t-test con-
trasts. Comparing 1st and 2nd round scans demonstrated
that there were no within scanner differences. In the
between scanner tests we found no significant differences
for the A-C contrasts and we found significant differences
in the A-B and B-C contrasts. The B-C white matter differ-
ences were more extensive that those found in the A-B
contrasts.
Adjusted VBM Results
We applied VBM analyses to the adjusted segmentations
obtained from the seven subjects who were excluded from
the scanner specific priors development process. The VBM
analyses applied were a direct replication of the baseline
tests. In these F-tests for the main effect of scanner we
found that there were no significant differences for either
the grey or white matter analyses. We repeated the
adjusted VBM analyses with all 13 CaliBrain subjects for
whom we had complete records and these analyses con-
firmed that no significant differences remained between
the pooled scanners.
Table 2: Grey matter metric results for the subjects excluded from priors generation
Scanner Comparison Baseline* Adjusted* Mean Difference (paired sample significance)
AA 2.8 (0.6) 2.8 (0.6) 0.00 (p < 1.00)
BB 3.4 (0.6) 3.4 (0.6) 0.00 (p < 1.00)
CC 2.6 (0.7) 2.5 (0.7) 0.05 (p < 0.078)
AB 7.3 (0.6) 5.1 (0.7) 2.2 (p < 0.001)
BC 8.2 (0.8) 5.5 (0.8) 2.7 (p < 0.001)
AC 4.0 (0.6) 3.6 (0.5) 0.36 (p < 0.003)
Grey matter metric results averaged over the seven subjects excluded from the scanner specific priors adjustment procedure. For the within and 
between scanner comparisons both baseline and adjusted absolute percentage distances are recorded.
*Absolute Percentage distance % (std dev)
Table 3: Grey Matter Baseline maximal voxel results
F-test Cluster Anatomical location Maximal voxel MNI coordinate FWE p_corrected
Right Temporal Pole 34, 15, -33 0.001
Left Temporal Pole -35, 16, -36 0.001
Left Inferior Parietal lobule -55, -48, 47 0.001
Left Inferior frontal gyrus -42, 45, -11 0.001
Thalamus 13, -10, -1 0.006
Right Inferior Parietal lobule 56, -48, 40 0.009
Left Middle frontal gyrus -43, 20, 46 0.014
Left Middle frontal gyrus -44, 44, 24 0.023
Cingulate gyrus 0, 46, 32 0.040
Brain stem -1, -30, -28 0.045
Right Superior frontal gyrus 15, 40, 49 0.052
VBM Grey matter baseline tests for the effect of scanner. Reporting the extent of the F-test cluster for an uncorrected threshold of p < 0.001. 
Giving the anatomical location of the maximal voxel, the MNI coordinate of this maximal voxel and the p_corrected significance.BMC Medical Imaging 2009, 9:8 http://www.biomedcentral.com/1471-2342/9/8
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Discussion
Combining structural MRI scans from different scanners
presents the possibility of increasing the statistical power
in VBM analyses of neuropsychiatric disorders. Our aim
was to refine the application of SPM segmentation proc-
esses and reduce the effects of scanner differences which
currently limit multi-centre MRI pooling [3,4]. We have
examined the application of the SPM5 priors based seg-
mentation to scans sourced from three scanners. The scan-
ners were matched by vendor, primary field strength, and
head coil type, and equivalent sequences were used at
each scanner. Although these scanners are well matched
we found in our baseline analyses significant between
scanner differences in the tissue segmentations. We have
demonstrated that if we employ scanner specific priors in
our application of SPM that these between scanner differ-
ences are reduced.
In VBM analyses the harmonisation constraints for the use
of multiple scanners are onerous as VBM requires the pro-
Grey Matter Baseline Results Figure 2
Grey Matter Baseline Results. Grey Matter Baseline Maximum Intensity Projection for the CaliBrain Project. Illustrates the 
regions where the scanners differ when the uncorrected threshold is p < 0.001.BMC Medical Imaging 2009, 9:8 http://www.biomedcentral.com/1471-2342/9/8
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Table 4: White Matter Baseline results
F-test Cluster Anatomical location Maximal voxel MNI coordinate FWE p_corrected
Right Middle frontal gyrus 18, 45, -19 0.021
Thalamus 15, -10, 0 0.053
VBM White matter baseline tests for the effect of scanner. Reporting the extent of the F-test cluster for an uncorrected threshold of p < 0.001. 
Giving the anatomical location of the maximal voxel, the MNI coordinate of this maximal voxel and the p_corrected significance.
White Matter baseline Results Figure 3
White Matter baseline Results. White matter baseline Maximum Intensity Projection for the CaliBrain project, Illustrates 
the regions where the scanners differ when the uncorrected threshold is p < 0.001.BMC Medical Imaging 2009, 9:8 http://www.biomedcentral.com/1471-2342/9/8
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vision of corrections for scanner differences at the voxel
level. Previous work has shown that it is possible to pool
scans from multiple centres in parcellated volumetric
studies. In a volumetric analysis of images from multiple
scanners [14], their semi-automated method applied glo-
bal corrections for the tissue classification which were
computed separately for each scanner. The methods
reported summary volumes for grey and white matter in
the cerebrum, and cerebellum and lateral ventricle vol-
umes [15]. This set-level segmentation method employed
global estimates of the intensity values that marked the
transitions between tissue types and CSF. These globally
applied transitions were adjusted for each scanning site.
A methodology that seeks to minimise the differences
between scanners through an integration of scan sequence
parameters into the segmentation functions was proposed
by [16] and gives global adjustment in the intensity to tis-
sue mapping. These global corrections are appropriate in
studies where the inferences drawn are limited to lobar tis-
sue occupancy. A volumetric method that addresses the
localised intensity to tissue mappings has been proposed
by [17] and recognises that localised adjustments for the
intensity to tissue mapping within the brain are necessary
for scan pooling to be valid for parcellation studies. The
method that we have proposed is in keeping with this
existing work as we have implemented corrections at a
scale that is close to the analysis scale for VBM.
Research for the Alzheimer's Disease Neuroimaging Initi-
ative (ADNI) project demonstrated that to pool scans
from multiple sites, it is important to minimise differ-
ences between pooled scanners [18-20]. The ADNI project
is a longitudinal analysis of ageing and in this within site
MRI reproducibility was tested on a range of scanners and
sequences. Based upon this research an MR-RAGE
sequence was recommended for multiple site scanning
and a scheme of corrections that includes field mapping
and geometry correction is applied. ADNI researchers
investigated the use of B1 field mapping to correct for
within scanner variation in the RF inhomogenity for
phased array head coils [20]. The results indicated that
this technique has limitations. However, B1 field map-
ping can be applied as an addition to the priors adjust-
ments protocol that we have developed. It is possible that
the inclusion of field mapping would further reduce the
between scanner differences in the CaliBrain project.
However, the scan time acquisitions necessary for correc-
tion of the B1 field are not available in the CaliBrain
project.
Recent reports of VBM analyses that sourced scans from
multiple scanners employed validation masks to limit the
reporting of results to regions where the scanner segmen-
tations were equivalent [3,4]. Meda [4] demonstrated in a
VBM study of psychosis at four centres that is possible to
limit the effects of scanner differences by validity masking
and ensuring that in the pooled analysis that the subjects
and controls are drawn equally from all contributing cen-
tres [4]. A VBM analysis of scans taken from six scanners
[3] reported that through the use of equivalent scan
sequences and good quality control, the extent of valida-
tion masking required could be limited to a single region
in the thalamus.
In the CaliBrain project we consider within scanner varia-
bility and between scanner differences and our aim was to
reduce the between scanner differences to the level of
within scanner variability. In keeping with the ADNI rec-
ommendations we have sought to minimise the scanner
differences in terms of vendor, field strength, head coil
and sequences. However, scanner B in the CaliBrain
project does differ from scanners A and C in terms of max-
imum gradient amplitude and maximum slew rate. Our
baseline results indicate that scanners A and C are well
matched and scans from these two sites could be pooled
without further adjustment or compensation. However,
our baseline results also demonstrate that scanner B
exhibits significant differences with respect to both scan-
ners A and C.
In order to reduce the differences between the scanners in
the CaliBrain project we have developed a procedure that
employs proportional feedback to adjust the priors for
each of the scanners. We have scan records for 13 healthy
subjects who were scanned twice at three scanners within
a six month period. We demonstrate our protocol for cre-
ating scanner specific priors using the 1st round scans of
six subjects. We test the adequacy of these scanner specific
priors through metric and VBM analyses. The tests for ade-
quacy are applied to the seven subjects who were excluded
from the priors adjustment protocol. These tests are lim-
ited by the number of subject scans available and we are
unable to evaluate the full effects of subject variation
expected in a multi-centre clinical study.
Clinical studies that could benefit from the scanner spe-
cific priors method are expected to have subject numbers
considerably greater than those available for the CaliBrain
project. In a multi-centre clinical study, with the exception
of the travelling subjects used to develop the scanner spe-
cific priors, the subjects would be recruited and scanned
independently at the contributing centres. In such a clini-
cal study a test for adequacy of scanner harmonisation
could be implemented through comparisons of the
healthy control scans recruited from the contributing cen-
tres [3,4].
The metric that we report assesses the absolute distance
between segmentations. The metrics are applied at theBMC Medical Imaging 2009, 9:8 http://www.biomedcentral.com/1471-2342/9/8
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voxel level and are averaged to report an overall distance
inclusive of noise and systematic differences. We report in
Table 1 on the scans that were used to implement the
scanner specific priors procedure. This indicates that the
within scanner variability ranges from 3.0% in scanner B
to 2.1% in scanners A and C. The adjustment process gives
rise to a reduction in the within scanner variability. How-
ever, the paired-t tests reveal that these within scanner
adjustments do not represent a significant change. In
Table 1 the baseline between scanner differences are at a
maximum for the BC comparison. Here the adjustment
procedure gave rise to significant reductions in all three
scanner comparison metrics.
In Table 2 we consider the effects of the scanner specific
priors on the scans of seven subjects who were excluded
from the priors adjustment process. At baseline the within
scanner variability and between scanner distances were
equivalent to the baseline results reported in Table 1.
Consequently, the use of the scanner specific priors
resulted in significant reductions in all three scanner com-
parisons. However, for the comparisons that include scan-
ner B, the reductions are not sufficient to bring the
between scanner difference down to the level of within
scanner variability.
The VBM analyses that we applied demonstrated that at
baseline there are no significant differences between scan-
ners A and C, However, we found that comparisons of
scanners A and C with scanner B gave rise to differences
that would require validity mapping such as that
employed in VBM analyses by [3,4]. After developing
scanner specific priors for scanners B and C and re-seg-
menting the scans we found that the requirement for
validity mapping was removed, because we recorded no
significant differences in the grey and white matter F-tests
for scanner effect.
Conclusion
Our results indicate the development of scanner specific
priors for the SPM application can assist in the pooling of
scan resources from different research centres. This devel-
opment can facilitate scan pooling and allow for improve-
ments in the statistical power of multi-centre brain
imaging studies. Our results indicate that six subjects were
adequate for the purpose of matching the scanners in the
CaliBrain project. In the typical clinical study the range of
tissue presentations would be expected to be greater than
that seen in our study of healthy controls. Thus it is likely
that in a clinical study that more than six travelling sub-
jects would be required. The number of travelling subjects
required would depend upon the diversity of tissue pres-
entation in the study and upon the nature of the differ-
ences in the scanners pooled. The method that we have
suggested may be limited to multi-site studies in which
there are no major hardware and acquisition protocol dif-
ferences across sites. The CaliBrain project uses scanners
from the same vendor all with the same field strengths
and head coils with matched sequences. This provides an
optimal environment for multiple site scan pooling. Dif-
ferent field strengths and image acquisition protocols
could have very different tissue contrasts that would lead
to marked differences in segmentation results. In such
cases the differences in tissue classification may well be
beyond the scope of our compensatory method.
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